Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Tamoxifen improves cholinergically modulated cognitive performance in postmenopausal women.

Newhouse P, Albert K, Astur R, Johnson J, Naylor M, Dumas J.

Neuropsychopharmacology. 2013 Dec;38(13):2632-43. doi: 10.1038/npp.2013.172.

2.

Estrogen treatment effects on anticholinergic-induced cognitive dysfunction in normal postmenopausal women.

Dumas J, Hancur-Bucci C, Naylor M, Sites C, Newhouse P.

Neuropsychopharmacology. 2006 Sep;31(9):2065-78.

3.
4.

Nicotinic versus muscarinic blockade alters verbal working memory-related brain activity in older women.

Dumas JA, Saykin AJ, McDonald BC, McAllister TW, Hynes ML, Newhouse PA.

Am J Geriatr Psychiatry. 2008 Apr;16(4):272-82. doi: 10.1097/JGP.0b013e3181602a2b.

5.

Endocrine therapy is associated with low performance on some estrogen-sensitive cognitive tasks in postmenopausal women with breast cancer.

Lejbak L, Vrbancic M, Crossley M.

J Clin Exp Neuropsychol. 2010 Oct;32(8):836-46. doi: 10.1080/13803391003596389.

PMID:
20336566
6.

Cholinergic modulation of hippocampal activity during episodic memory encoding in postmenopausal women: a pilot study.

Dumas JA, McDonald BC, Saykin AJ, McAllister TW, Hynes ML, West JD, Newhouse PA.

Menopause. 2010 Jul;17(4):852-9. doi: 10.1097/gme.0b013e3181e04db9.

7.

Use of medications with anticholinergic properties and cognitive function in a young-old community sample.

Low LF, Anstey KJ, Sachdev P.

Int J Geriatr Psychiatry. 2009 Jun;24(6):578-84. doi: 10.1002/gps.2157.

PMID:
19021151
8.

Estrogen treatment impairs cognitive performance after psychosocial stress and monoamine depletion in postmenopausal women.

Newhouse PA, Dumas J, Wilkins H, Coderre E, Sites CK, Naylor M, Benkelfat C, Young SN.

Menopause. 2010 Jul;17(4):860-73. doi: 10.1097/gme.0b013e3181e15df4.

9.

Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) Study.

Kritz-Silverstein D, Von Mühlen D, Barrett-Connor E, Bressel MA.

Menopause. 2003 May-Jun;10(3):196-202.

PMID:
12792289
10.

Cognitive factors associated with adherence to oral antiestrogen therapy: results from the cognition in the study of tamoxifen and raloxifene (Co-STAR) study.

Klepin HD, Geiger AM, Bandos H, Costantino JP, Rapp SR, Sink KM, Lawrence JA, Atkinson HH, Espeland MA.

Cancer Prev Res (Phila). 2014 Jan;7(1):161-8. doi: 10.1158/1940-6207.CAPR-13-0165.

11.

Estradiol treatment altered anticholinergic-related brain activation during working memory in postmenopausal women.

Dumas JA, Kutz AM, Naylor MR, Johnson JV, Newhouse PA.

Neuroimage. 2012 Apr 2;60(2):1394-403. doi: 10.1016/j.neuroimage.2012.01.043.

12.

Endometrial polyps: a comparison study of patients receiving tamoxifen with two control groups.

Schlesinger C, Kamoi S, Ascher SM, Kendell M, Lage JM, Silverberg SG.

Int J Gynecol Pathol. 1998 Oct;17(4):302-11.

PMID:
9785130
13.

Effects of tamoxifen and raloxifene on memory and other cognitive abilities: cognition in the study of tamoxifen and raloxifene.

Legault C, Maki PM, Resnick SM, Coker L, Hogan P, Bevers TB, Shumaker SA.

J Clin Oncol. 2009 Nov 1;27(31):5144-52. doi: 10.1200/JCO.2008.21.0716.

14.

Estrogen-cholinergic interactions: Implications for cognitive aging.

Newhouse P, Dumas J.

Horm Behav. 2015 Aug;74:173-85. doi: 10.1016/j.yhbeh.2015.06.022. Review.

15.

Cognitive functioning during long-term tamoxifen treatment in postmenopausal women with breast cancer.

Boele FW, Schilder CM, de Roode ML, Deijen JB, Schagen SB.

Menopause. 2015 Jan;22(1):17-25. doi: 10.1097/GME.0000000000000271.

PMID:
24977455
16.

Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women.

Nickelsen T, Lufkin EG, Riggs BL, Cox DA, Crook TH.

Psychoneuroendocrinology. 1999 Jan;24(1):115-28.

PMID:
10098223
17.

Zeatin supplement improves scopolamine-induced memory impairment in mice.

Kim MJ, Choi SJ, Lim ST, Kim HK, Kim YJ, Yoon HG, Shin DH.

Biosci Biotechnol Biochem. 2008 Feb;72(2):577-81.

18.

Effects of the antiestrogen tamoxifen on low-density lipoprotein concentrations and oxidation in postmenopausal women.

Guetta V, Lush RM, Figg WD, Waclawiw MA, Cannon RO 3rd.

Am J Cardiol. 1995 Nov 15;76(14):1072-3.

PMID:
7484866
19.

Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia.

Weickert TW, Weinberg D, Lenroot R, Catts SV, Wells R, Vercammen A, O'Donnell M, Galletly C, Liu D, Balzan R, Short B, Pellen D, Curtis J, Carr VJ, Kulkarni J, Schofield PR, Weickert CS.

Mol Psychiatry. 2015 Jun;20(6):685-94. doi: 10.1038/mp.2015.11.

20.

Cognitive performance and cholinergic transmission: influence of muscarinic and nicotinic receptor blockade.

Voss B, Thienel R, Reske M, Habel U, Kircher T.

Eur Arch Psychiatry Clin Neurosci. 2010 Nov;260 Suppl 2:S106-10. doi: 10.1007/s00406-010-0160-8.

PMID:
20960003
Items per page

Supplemental Content

Support Center